Truphone to Lead an Invisible Revolution at Mobile World Congress 2023
22.2.2023 16:25:00 EET | Business Wire | Press release
Truphone, the pioneering global connectivity provider, today announced it will be showcasing its industry-leading innovations at the upcoming Mobile World Congress (MWC) event in Barcelona, from February 27th to March 2nd, 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230222005594/en/
Truphone to Lead an Invisible Revolution at Mobile World Congress 2023 (Graphic: Business Wire)
Presenting from Booth 7B71, Hall 7, Truphone will reveal how it’s driving the “Invisible Revolution” of truly global, seamless cellular connectivity by unveiling products such as eSIM Launch Pad, its world-class Remote SIM Provisioning and Entitlements Server platform that brings even more value to its eSIM offering for mobile carriers and device makers.
They’ll also be presenting a cutting-edge demonstration of how their leadership position on the game-changing new SGP.31 eSIM Internet of Things (IoT) Architecture and Requirements Specification embodies their commitment to delivering choice and freedom. By removing operator lock-in and democratising connectivity for the entire IoT connectivity ecosystem, Truphone is paving the way for new opportunities and growth for cellular IoT technologies.
At the booth, attendees will also have the opportunity to meet with Truphone's senior team and industry experts, as well as Hakan Koç, one of Truphone’s two new co-owners, to learn more about the company's new vision and strategy.
"We’re thrilled to be exhibiting at MWC 2023 and showcasing our latest technologies to the telecommunications industry," said Harry Odenhoven, CEO of Truphone. "We believe that Truphone is at the forefront of transforming the landscape of global cellular connectivity by providing more choice and freedom than any other provider, and we’re excited to demonstrate our commitment to that by sharing our vision for the future."
With a track record of pioneering industry-firsts, Truphone has become one of the world's most respected telecommunications and connectivity companies. By leveraging its global network infrastructure and technology, Truphone is transforming the way businesses and consumers connect and communicate, delivering true mobility and flexibility to its customers.
To learn more about Truphone is driving the Invisible Revolution and helping to shape the way the world connects, visit the company at MWC 2023 at Booth 7B71, Hall 7.
About Truphone
We’re on a mission to connect the world seamlessly.
That’s why we aim to enable more connections than anyone else and why we’ve been pioneering the eSIM revolution from the very beginning.
From international enterprises and consumers to IOT device makers and Telecommunications operators, our global network and connectivity solutions enable people, devices and networks to connect anywhere, instantly, with one platform to connect billions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230222005594/en/
Contact information
Guy Thornton
Head of Product Marketing
07702 443568
guy.thornton@truphone.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ryan Expands UK Business Rates and Property Tax Capabilities with Acquisition of WYM Rating5.2.2026 10:00:00 EET | Press release
Ryan, a leading global tax services and software provider, is pleased to announce the acquisition of Williams Young McKaig Ltd, a specialized commercial property consultancy, and its specialist rating division, WYM Rating, based in Edinburgh. The acquisition establishes Ryan’s property tax and business rates presence in Scotland and expands the Firm’s ability to serve clients with complex commercial property portfolios across the United Kingdom. Founded in 2012 by Richard Williams, Don Young, and Billy McKaig, WYM Rating is recognized for its client-centered approach and deep expertise across commercial property advisory. The consultancy supports landlords, occupiers, and investors through practical, market-informed advice grounded in decades of hands-on experience. WYM Rating’s capabilities span three focus areas, closely aligning with Ryan’s capabilities: Business rates and property tax Commercial property advisory Occupier and lease advisory “WYM Rating brings exactly the kind of sp
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release
Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob
Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release
VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom